• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Revance Therapeutics Inc

+ Add to Watchlist

RVNC:US

31.5300 USD 0.1400 0.45%

As of 20:10:00 ET on 07/24/2014.

Snapshot for Revance Therapeutics Inc (RVNC)

Open: 31.3600 Day's Range: 31.0500 - 32.0000 Volume: 104,103
Previous Close: 31.3900 52wk Range: 16.0000 - 39.8600 1-Yr Rtn: -

Stock Chart for RVNC

No chart data available.
  • RVNC:US 31.4100
  • 1D
  • 1M
  • 1Y
31.3900
Interactive RVNC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RVNC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.8370
Est. PEG Ratio -
Market Cap (M USD) 714.26
Shares Outstanding (M) 22.65
30 Day Average Volume 194,565
Price/Book (mrq) 7.4744
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RVNC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RVNC

Revance Therapeutics, Inc. produces biopharmaceutical products. The Company develops drug delivery and treatments for dermatology and aesthetic medicine. Revance Therapeutics serves patients and doctors throughout the United States.

L Daniel Browne "Dan"President/CEO/Co-FounderJacob WaughChief Scientific Ofcr/Dir:Medical
Lauren P SilvernailExec VP:Corporate Dev/CFOCurtis RueggExec VP:Research & Dev
More Company Profile & Key Executives for RVNC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil